Exhibit Item
Biotech specialized with hair loss treatments, possessing various modalities such as cell therapy, antibody drug, small molecule(synthetic drugs,) and etc. We have received the first IND approval for Dermal Papilla Cell therapy and entering phase 1/2a. Also, developing the 'First-in-Class' antibody therapy, which would be the first antibody for androgenic alopecia. Related to controlling inflammation/immune response, it would be the ultimate treatment for intractable alopecia. Our small molecule drug, which is developed as topical treatment, has shown superior efficacy in female pattern hair loss compared to conventional treatments. Also, providing various CRO services with various animal models including alopecia areata model.
KYUNGYON EXHIBITION CORP.